A synthetic palm oil manufacturer has raised US$20m in funding to scale its technology and prepare the business for commercial launch.
C16 Biosciences uses
The financial backers for C16 Bioscience include also beauty investment specialists Waldencast
A synthetic palm oil manufacturer has raised US$20m in funding to scale its technology and prepare the business for commercial launch.
C16 Biosciences uses